Biography

Andrew Z. Wang, M.D., Professor (Tenure), holds the A. Kenneth Pye Professorship in Cancer Research and is the Vice Chair for Translational Research and Commercialization in the Department of Radiation Oncology.

Dr. Wang earned two Bachelor of Science degrees in Biochemistry and Biology and a Bachelor of Arts degree in Mathematics from Indiana University with highest distinction. He obtained his medical degree from the Harvard-MIT Health Sciences and Technology (HST) program at Harvard Medical School. After an internship in internal medicine at St. Luke’s Roosevelt Hospital in New York, he completed clinical training in radiation oncology in the Harvard Radiation Oncology Program. During residency, he also completed a postdoctoral fellowship  at Massachusetts Institutes of Technology under the mentorship of Dr. Robert Langer. Following residency, Dr. Wang joined the faculty of University of North Carolina as Assistant Professor in the Department of Radiation Oncology in 2009, where he rose to the rank of Tenured Professor. Dr. Wang joined UTSW faculty in 08/2021.

Dr. Wang’s research program is focused on the application of biomedical engineering to cancer research. His group aims to develop novel cancer diagnostics and therapeutics to improve cancer treatment. His work is high impact and highly innovative and has resulted in 15+ patents/patent applications (5 granted patents) and three biotechnology startup companies. His work has been published in high impact journals such as Nature Nanotechnology, Advanced Materials, and Nature Biotechnology. Because of his research accomplishments, Dr. Wang has been elected as a member of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows and the American Society for Clinical Investigation (ASCI).

Clinically, Dr. Wang specializes in the treatment of genitourinary and gastrointestinal cancers. He is familiar with different radiation techniques, including IMRT, IGRT, linac-based SRS, SBRT, and intraoperative radiotherapy and interstitial brachytherapy.

Education

Medical School
Harvard Medical School (2004)
Internship
Columbia University/St. Luke's - Roosevelt Hospital Center (2005), Internal Medicine
Residency
Harvard/Brigham and Women's Hospital/Massachusetts General Hospital (2009)

Research Interest

  • Application of biomedical engineering to cancer research
  • cancer metastasis
  • Developing novel cancer diagnostics and therapeutics to improve cancer treatment
  • nanomedicine

Publications

Featured Publications LegendFeatured Publications

Books

Featured Books Legend Featured Books

Honors & Awards

  • America's Top Doctors by Castle Connolly
    (2020)
  • Elected Member of the American Society for Clinical Investigation (ASCI)
    (2020)
  • American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
    (2019)
  • ASCO Leadership Development Program
    (2019)
  • Associate Scientific Advisor, Science Translational Medicine
    (2016-2016)
  • UNC Health Care and Faculty Physicians Award for Carolina Care Excellence
    (2016-2021)
  • ASTRO Biology Basic Science Research Abstract Award
  • ASTRO Junior Faculty Basic Science Research Abstract Award
  • Betty and Doris Barrett Scholarship, Harvard Medical School
  • Howard Hughes Medical Institute Research Fellowship for Medical Students

Professional Associations/Affiliations

  • The American Society for Clinical Investigation (2020)
  • The American Institute for Medical and Biological Engineering (AIMBE) (2019)
  • Associate Editor, BMC Cancer (2018)
  • Journal of the National Cancer Institute, Member, Editorial Board (2017)
  • Nanomedicine: Nanotechnology, Biology, and Medicine, Associate Editor (2015)
  • American Society of Clinical Oncology (ASCO) (2009)
  • American Association for Cancer Research (AACR) (2007)
  • American Society for Radiation Oncology (ASTRO) (2006)